Skip to main content
Equibles

Dana Investment Advisors, Inc.

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1427514 BROOKFIELD, WI
Back to AXSM Full portfolio

Position in AXSM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,592,994
+$1,134,416 QoQ
Shares Held
22,850
-13.4% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#160
of 504 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. AXSM ranks #2 (13.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 57,520 $18,181,496
2 AXSM
Axsome Therapeutics, Inc.
This page 		22,850 $5,592,994
3 REGN
Regeneron Pharmaceuticals, Inc.
 7,719 $4,813,105
4 TGTX
Tg Therapeutics, Inc.
 42,012 $2,308,139
5 VKTX
Viking Therapeutics, Inc.
 57,854 $2,256,884
6 MDGL
Madrigal Pharmaceuticals, Inc.
 3,677 $1,974,365
7 ZYME
Zymeworks Inc.
 71,660 $1,873,192
8 IONS
Ionis Pharmaceuticals Inc
 23,272 $1,845,236

All Filings in AXSM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,592,994 22,850
2026-03-31 $4,458,578 26,379
2025-12-31 $6,063,100 33,197
2025-09-30 $4,082,177 33,612
2025-06-30 $2,512,980 24,073
2025-03-31 $1,319,435 11,313
2024-12-31 $1,387,096 16,394
2024-09-30 $1,579,644 17,577
2024-06-30 $1,587,782 19,724
2024-03-31 $1,518,354 19,027
2023-12-31 $1,085,687 13,641
2023-09-30 $988,803 14,148
2023-06-30 $1,265,885 17,616
2023-03-31 $1,162,421 18,846
2022-12-31 $1,459,762 18,926
2022-09-30 $663,276 14,865
2022-06-30 $669,254 17,474
2022-03-31 $662,488 16,006
2021-12-31 $741,205 19,619
2021-09-30 $1,001,160 30,375
2021-06-30 $1,338,946 19,848
2021-03-31 $1,038,524 18,342